When Should You Up Your Dose of Mounjaro?

What signals tell you the current dose is ready to leave behind?

The main cue is a settled stomach. In the first couple of weeks on any new Mounjaro dose, nausea, loose stools or a heavy feeling after eating are common, that's the gut adjusting to a slower gastric emptying rate. If those symptoms are still loud at the four-week mark, moving up would simply stack more on top of them. Once nausea has quietened to the background and meals feel reasonably normal again, the body has usually adapted enough to handle the next step.

Weight response matters too, though not in the way people often expect. A stall in week three of a dose isn't a reason to rush upwards; the medicine's appetite effect continues to build across that whole four-week window. The clearer signal is a plateau that persists across the full period at the current dose, little or no change across several weekly weigh-ins despite sticking to the programme.

The NHS tirzepatide guidance describes the titration structure plainly: increases happen at the prescriber's direction, not on a fixed calendar. That framing matters. Four weeks is the minimum, not a countdown to the next pen. Some people stay at 5mg or 7.5mg for longer and continue to lose weight steadily, going higher isn't always necessary.

If you're weighing up whether moving to 5mg Mounjaro is the right call for you, the detail on whether you should go up a dose on Mounjaro covers the specific questions worth asking at that stage.

Are there reasons to hold off on a dose increase even when you feel fine?

Yes, and this catches people out. Feeling well on the current dose is necessary but not sufficient. A few other factors pause the clock.

Illness changes everything. If you've had a stomach bug, a heavy cold or any acute illness in the days before your review, your gut is already under pressure. Moving up during or immediately after illness makes it very hard to tell whether new nausea is the dose or the virus. Prescribers typically recommend waiting until you've been well for a week or so before stepping up.

Recent changes to other medicines can also shift the picture. Tirzepatide slows gastric emptying, which affects how quickly oral medicines absorb. If your GP has recently adjusted something else you take, that conversation belongs with your prescriber before any dose change. The NHS England guidance on weight-management injections sets out some of the interaction considerations worth discussing, including why women using the combined oral contraceptive pill should add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced.

Travel is another practical one. If you know you'll be away from the fridge (a two-week holiday, a work trip abroad) starting a new dose the week before you leave is rarely sensible. Many people quietly time their step-up for when they're back home and settled. There's no shame in that; a Monday in January when you're back at your routine is a perfectly good moment to go up. For more on the decision in general, the guide to whether you should increase your Mounjaro dose walks through the fuller checklist.

What does the actual dose schedule look like in practice?

The licensed UK strengths run from 2.5mg up to 15mg: 2.5, 5, 7.5, 10, 12.5, and 15mg. Each pen contains four weekly doses. The starting pen (2.5mg) is strictly a tolerability dose, its job is to give your system a gentle introduction, not to produce significant weight loss on its own. Most people notice little appetite change at 2.5mg, which is expected and correct.

From 5mg onwards the therapeutic effect builds. Trial data from SURMOUNT-1, published in the New England Journal of Medicine, found that participants who reached higher maintenance doses saw average body-weight reductions in the region of 20% over 72 weeks, a figure that underscores why getting the titration right matters more than rushing it. The 5mg Mounjaro page covers what to expect at that specific stage in more detail.

In practice, a typical titration might look like: 2.5mg for weeks 1–4, then 5mg for weeks 5–8, then a clinical review that decides whether to move to 7.5mg or hold. None of those steps are automatic. Each one needs a prescriber to confirm you're tolerating the current dose and still making progress. At our pharmacy, that review happens before every repeat, a real clinician reads your update, not software, the same day it comes in.

Thinking about the cost of stepping through multiple doses over several months? The Eli Lilly UK price increase page sets out what happened to Mounjaro's list price from September 2025, and what that means for private treatment costs, useful context for planning ahead.

Can you ever go back down a dose, and does that affect the plan?

Yes, and it's more common than the titration chart makes it look. If a dose increase brings side effects that feel unmanageable (persistent vomiting, significant nausea affecting daily life, or a reaction that worries you) stepping back down to the previous dose is a legitimate clinical option, not a failure. The aim is the highest dose you can tolerate well, which isn't the same as the highest dose available.

Prescribers sometimes describe this as finding your maintenance sweet spot. For some people that's 7.5mg; for others it's 12.5mg. There's no award for reaching 15mg fastest. If you're unsure about the right moment to move back upward, the guidance on when you should go up a dose on Mounjaro covers the criteria for stepping back up after a temporary reduction, it's a slightly different calculation, since you've already proved you can tolerate the lower level.

If you're finding decisions like this hard to navigate alone, that's exactly the kind of question our prescribers field regularly. The clinical review built into every repeat order is the right moment to raise it. You can also explore the broader weight-loss treatment options if you're at an earlier stage of deciding whether Mounjaro is right for you at all, or head straight to the free consultation to talk it through with a prescriber.